Standardization of Allergen-Specific Immunotherapy Vaccines - 16/08/11
, Jørgen Nedergaard Larsen, PhDRésumé |
In the 1970s and 1980s, scientific methods were introduced in the standardization of allergen vaccines and, in combination with improved documentation of the clinical benefits obtained using standardized vaccines, specific allergy treatment as a scientifically based, reproducible, and safe treatment for allergic disease was established. This article describes important issues in the control of source materials and vaccine preparation as part of the European standardization of allergen vaccines, and also includes a discussion of vaccines that are based on recombinant allergens, which may appear on the market in the near future.
Le texte complet de cet article est disponible en PDF.Plan
Vol 26 - N° 2
P. 191-206 - mai 2006 Retour au numéro
Article précédent
- Allergy Diagnosis, Allergen Repertoires, and Their Implications for Allergen-Specific Immunotherapy
- Reto Crameri
- Mechanisms of Allergen-Specific Immunotherapy: T-Regulatory Cells and More
- Johan Verhagen, Kurt Blaser, Cezmi A. Akdis, Mübeccel Akdis
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?